Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
OMICS ; 25(11): 681-692, 2021 11.
Article in English | MEDLINE | ID: covidwho-1541502


Multiomics study designs have significantly increased understanding of complex biological systems. The multiomics literature is rapidly expanding and so is their heterogeneity. However, the intricacy and fragmentation of omics data are impeding further research. To examine current trends in multiomics field, we reviewed 52 articles from PubMed and Web of Science, which used an integrated omics approach, published between March 2006 and January 2021. From studies, data regarding investigated loci, species, omics type, and phenotype were extracted, curated, and streamlined according to standardized terminology, and summarized in a previously developed graphical summary. Evaluated studies included 21 omics types or applications of omics technology such as genomics, transcriptomics, metabolomics, epigenomics, environmental omics, and pharmacogenomics, species of various phyla including human, mouse, Arabidopsis thaliana, Saccharomyces cerevisiae, and various phenotypes, including cancer and COVID-19. In the analyzed studies, diverse methods, protocols, results, and terminology were used and accordingly, assessment of the studies was challenging. Adoption of standardized multiomics data presentation in the future will further buttress standardization of terminology and reporting of results in systems science. This shall catalyze, we suggest, innovation in both science communication and laboratory medicine by making available scientific knowledge that is easier to grasp, share, and harness toward medical breakthroughs.

Computational Biology/trends , Genomics/trends , Metabolomics/trends , Proteomics/trends , Animals , COVID-19 , Computer Graphics , Epigenomics/trends , Gene Expression Profiling/trends , Humans , Pharmacogenetics/trends , Publications , SARS-CoV-2 , Terminology as Topic
Adv Drug Deliv Rev ; 172: 249-274, 2021 05.
Article in English | MEDLINE | ID: covidwho-1064699


SARS-CoV-2, which causes COVID-19, was first identified in humans in late 2019 and is a coronavirus which is zoonotic in origin. As it spread around the world there has been an unprecedented effort in developing effective vaccines. Computational methods can be used to speed up the long and costly process of vaccine development. Antigen selection, epitope prediction, and toxicity and allergenicity prediction are areas in which computational tools have already been applied as part of reverse vaccinology for SARS-CoV-2 vaccine development. However, there is potential for computational methods to assist further. We review approaches which have been used and highlight additional bioinformatic approaches and PK modelling as in silico methods which may be useful for SARS-CoV-2 vaccine design but remain currently unexplored. As more novel viruses with pandemic potential are expected to arise in future, these techniques are not limited to application to SARS-CoV-2 but also useful to rapidly respond to novel emerging viruses.

COVID-19 Vaccines/administration & dosage , COVID-19/prevention & control , Computational Biology/methods , Drug Development/methods , SARS-CoV-2/drug effects , Animals , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , COVID-19/genetics , COVID-19/immunology , COVID-19 Vaccines/genetics , COVID-19 Vaccines/immunology , Computational Biology/trends , Drug Development/trends , Epitopes/genetics , Epitopes/immunology , Gene Expression Profiling/methods , Gene Expression Profiling/trends , Humans , SARS-CoV-2/genetics , SARS-CoV-2/metabolism